Characterization of Acute Prescription Migraine Medication Use-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of Acute Prescription Migraine Medication Use

Published:2020-04 Issue:4 Volume:95 Page:709-718
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Hutchinson Susan,Lipton Richard B.,Ailani Jessica,Reed Michael L.,Fanning Kristina M.,Adams Aubrey Manack,Buse Dawn C.

Funder

Allergan plc

National Institutes of Health

Migraine Research Foundation

National Headache Foundation

National Institute on Aging

American Migraine Foundation

Allergan

Biohaven

Amgen

Lilly

GlaxoSmithKline

Merck

Novartis

Publisher

Elsevier BV

Subject

General Medicine

Reference33 articles.

1. Migraine–current understanding and treatment;Goadsby;N Engl J Med,2002

2. The International Classification of Headache Disorders, 3rd edition;Cephalalgia,2018

3. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS);Blumenfeld;Cephalalgia,2011

4. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study;Buse;Headache,2012

5. Comparisons of disability, quality of life, and resource use between chronic and episodic migraineurs: a clinic-based study in Taiwan;Wang;Cephalalgia,2013

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing barriers to care in migraine: multicountry results from the Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) study;The Journal of Headache and Pain;2024-08-19

2. Rimegepant orally disintegrating tablet 75 mg for acute treatment of migraine in adults from China: a subgroup analysis of a double-blind, randomized, placebo-controlled, phase 3 clinical trial;The Journal of Headache and Pain;2024-04-16

3. Migraine treatment: quo vadis? Real-world data study (2015–2022) in Spain;BMC Neurology;2024-04-02

4. Medication “underuse” headache;Cephalalgia;2024-04

5. Evaluation of the pharmacokinetic interactions and safety of atogepant coadministered with esomeprazole;Pain Management;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3